Abstract
Aims: Extra virgin olive oil lowers postprandial glycaemia. We investigated if oleuropein, a component of extra virgin olive oil, exerts a similar effect on postprandial glycaemia and the underlying mechanism. Methods: Twenty healthy subjects were randomly allocated in a cross-over design to 20 mg oleuropein or placebo immediately before lunch. Postprandial glycaemia along with blood insulin, dipeptidyl-peptidase-4 (DPP-4) and glucagon-like peptide-1 and oxidative stress, which included soluble NADPH oxidase-derived peptide activity (sNox2-dp), 8-iso-prostaglandin-2α and platelet p47phox phosphorylation, were analysed before and 2 h after meal. Results: After 2 h, subjects who assumed oleuropein had significantly lower blood glucose, DPP-4 activity and higher insulin and glucagon-like peptide-1 compared to placebo. Furthermore, sNox2-dp, 8-iso-PGF2α and platelet p47phox phosphorylation were significantly lower in oleuropein- compared to placebo-treated subjects. DPP-4 significantly correlated with sNox2-dp [Spearman's rho (Rs) = 0.615; P < 0.001], p47phox phosphorylation (Rs = 0.435; P < 0.05) and 8-iso- prostaglandin-2α (Rs = 0.33; P < 0.05). In vitro study demonstrated that hydroxytyrosol, a metabolite of oleuropein, significantly reduced p47phox phosphorylation and isoprostane formation. Conclusions: These findings indicate that oleuropein improves postprandial glycaemic profile via hampering Nox2-derived oxidative stress.
Author supplied keywords
Cite
CITATION STYLE
Carnevale, R., Silvestri, R., Loffredo, L., Novo, M., Cammisotto, V., Castellani, V., … Violi, F. (2018). Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects. British Journal of Clinical Pharmacology, 84(7), 1566–1574. https://doi.org/10.1111/bcp.13589
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.